PROMUS^® Everolimus-Eluting Coronary Stent System

The right olimus, the right platform, from the right partner

The PROMUS Stent System combines a highly deliverable platform with an effective drug and polymer design to provide an optimal olimus, from a partner you trust.

Effective Drug and Polymer Design

• Everolimus is highly lipophilic¹
• Low drug load²
• Thin, fluorinated copolymer matrix for controlled drug release
  (100% drug elution in 120 days)³

Exceptional Deliverability

• Thin 0.0032" cobalt chromium struts for increased flexibility and conformability without compromise to radiopacity^2,3
• Low 0.042" stent profile for enhanced deliverability⁴

Device Illustration

1.  Wire/Catheter Holder
2.  Adaption Cup
3.  Proximal Marker
4.  Proximal Shaft
5.  Mid-Shaft
6.  Guide Wire Exit Notch
7a. Distal Shaft
7b. Stent
7c. Distal Tip
8a. Balloon
8b. Balloon Marker Bands

Excellent Angiographic and Clinical Results⁵

The SPIRIT Clinical Trial Program demonstrates the safety and efficacy of the XIENCE V® (PROMUS) Stent.

Consistently low late loss and TLR...

...with long-term safety data.

Additional Information

¹  Grube E, Sonoda S, Ikeno F, et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation. 2004;109:2168-2171.
² PROMUS Stent Directions for Use (DFU).
³  Data on file at Boston Scientific Corporation.
⁴  Testing of 3.0mm stent completed by Boston Scientific Corporation. Data on file. Bench test results may not necessarily be indicative of clinical performance.
⁵  SPIRIT sponsored by Abbott. SPIRIT FIRST 6-month data: Serruys PW, Ong A, Piek J. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT FIRST Trial. EuroIntervention. 2005;1:58-65. SPIRIT FIRST 4-Year Results Presentation, PCR 2008; presented by Dr. Stephen Windecker. SPIRIT II 6-Month Results Presentation, ESC 2006; presented by Dr. Patrick Serruys. SPIRIT II 2-Year Results Presentation, ACC 2008; presented by Dr. Patrick Serruys. SPIRIT II 4-Year Results Presentation, ACC 2010; presented by Dr. Yoshinobu Onuma. SPIRIT III 9-Month Results Presentation, ACC 2007; presented by Dr. Gregg W. Stone. SPIRIT III 2-Year Results Presentation, PCR 2008; presented by Dr. Gregg W. Stone.

PROMUS Stent is a private-labeled XIENCE V® Everolimus Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific Corporation.

Multi-Link Vision and XIENCE V are trademarks of Abbott Laboratories group of companies.